Who are Duavive 0.45Mg-20Mg Tablet's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Duavee, Duavee, Femring, Evista, Premarin, Premarin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/duavive-0-45mg-20mg-tablet.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Duavive 0.45Mg-20Mg Tablet — Competitive Intelligence Brief

Duavive 0.45Mg-20Mg Tablet (duavive-0-45mg-20mg-tablet) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: estrogen receptor modulator.

marketed estrogen receptor modulator estrogen receptors Live · refreshed every 30 min

Target snapshot

Duavive 0.45Mg-20Mg Tablet (duavive-0-45mg-20mg-tablet) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Duavive 0.45Mg-20Mg Tablet TARGET	duavive-0-45mg-20mg-tablet	Pfizer	marketed	estrogen receptor modulator	estrogen receptors
Duavee	conjugated-estrogens-bazedoxifene	Pfizer	marketed	Estrogen [EPC]	estrogen receptors α and β	2013-01-01
Duavee	BAZEDOXIFENE	Wyeth Pharms Pfizer	marketed	Estrogen [EPC]	estrogen receptors (ER) α and β	2013-01-01
Femring	ESTRADIOL ACETATE	Apil	marketed	Estrogen	estrogen receptors	2003-01-01
Evista	RALOXIFENE	Eli Lilly	marketed	Estrogen Agonist/Antagonist	estrogen receptors	1997-01-01
Premarin	Estrogens, Conjugated	Pfizer	marketed	Estrogen replacement therapy	Estrogen receptors (nuclear receptors)	1942-01-01
Premarin	Estrogens, Conjugated	Pfizer	marketed	Estrogen replacement therapy	Estrogen receptors (nuclear receptors)	1942-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2027-03-10 — Duavee · 7683051 · US
2028-07-10 — Femring · 9730900 · Method of Use · US
2028-07-10 — Femring · 9724310 · Compound · US
2028-07-10 — Femring · 9833419 · Formulation · US
2030-07-04 — Femring · 8231906 · Compound · US
2032-11-21 — Femring · 10537581 · Formulation · US
2032-11-21 — Femring · 11246875 · Method of Use · US
2032-11-21 — Femring · 11241445 · Method of Use · US
2032-11-21 — Femring · 10668082 · Method of Use · US
2032-11-21 — Femring · 10568891 · Method of Use · US
2032-11-21 — Femring · 9180091 · Formulation · US
2032-11-21 — Femring · 11497709 · Method of Use · US
2032-11-21 — Femring · 10835487 · Method of Use · US
2032-11-21 — Femring · 10888516 · Method of Use · US
2032-11-21 — Femring · 11351182 · Method of Use · US
2032-11-21 — Femring · 11116717 · Formulation · US
2032-11-21 — Femring · 11065197 · Formulation · US
2032-11-21 — Femring · 10258630 · Method of Use · US
2032-11-21 — Femring · 11123283 · Formulation · US
2032-11-21 — Femring · 9289382 · Formulation · US
2032-11-21 — Femring · 10806697 · Formulation · US
2032-11-21 — Femring · 10398708 · Method of Use · US
2032-11-21 — Femring · 10471072 · Method of Use · US
2032-11-21 — Femring · 11304959 · Formulation · US
2034-02-02 — Femring · 11266661 · Method of Use · US

Sponsor landscape (estrogen receptor modulator class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Duavive 0.45Mg-20Mg Tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/duavive-0-45mg-20mg-tablet. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab